Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of lymphatic vessel | 4 studies | 26% ± 6% |
Insufficient scRNA-seq data for expression of ART4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 99% | 1289.97 | 223 / 226 | 90% | 11.19 | 365 / 406 |
pancreas | 75% | 128.91 | 245 / 328 | 64% | 2.42 | 114 / 178 |
kidney | 82% | 291.66 | 73 / 89 | 38% | 1.33 | 344 / 901 |
thymus | 98% | 573.02 | 642 / 653 | 20% | 0.44 | 122 / 605 |
adrenal gland | 83% | 199.40 | 214 / 258 | 27% | 0.58 | 61 / 230 |
lung | 92% | 280.88 | 533 / 578 | 14% | 0.52 | 162 / 1155 |
spleen | 100% | 1152.44 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 955.89 | 1326 / 1335 | 0% | 0 | 0 / 0 |
heart | 93% | 600.63 | 801 / 861 | 0% | 0 | 0 / 0 |
adipose | 87% | 284.98 | 1048 / 1204 | 0% | 0 | 0 / 0 |
uterus | 65% | 131.22 | 110 / 170 | 2% | 0.15 | 7 / 459 |
breast | 53% | 87.50 | 242 / 459 | 7% | 0.86 | 75 / 1118 |
prostate | 19% | 27.20 | 47 / 245 | 29% | 1.32 | 148 / 502 |
bladder | 38% | 38.43 | 8 / 21 | 7% | 0.41 | 33 / 504 |
intestine | 34% | 50.43 | 324 / 966 | 6% | 0.34 | 34 / 527 |
lymph node | 0% | 0 | 0 / 0 | 38% | 0.75 | 11 / 29 |
esophagus | 28% | 39.36 | 406 / 1445 | 3% | 0.08 | 5 / 183 |
skin | 12% | 15.73 | 213 / 1809 | 9% | 0.32 | 44 / 472 |
ovary | 19% | 60.29 | 35 / 180 | 0% | 0.00 | 1 / 430 |
stomach | 11% | 18.77 | 41 / 359 | 5% | 0.11 | 15 / 286 |
peripheral blood | 12% | 20.42 | 107 / 929 | 0% | 0 | 0 / 0 |
muscle | 10% | 10.07 | 79 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.14 | 4 / 45 |
brain | 0% | 0 | 0 / 2642 | 0% | 0.00 | 2 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006525 | Biological process | arginine metabolic process |
GO_0098552 | Cellular component | side of membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0016779 | Molecular function | nucleotidyltransferase activity |
GO_0003950 | Molecular function | NAD+ ADP-ribosyltransferase activity |
GO_0106274 | Molecular function | NAD+-protein-arginine ADP-ribosyltransferase activity |
Gene name | ART4 |
Protein name | ADP-ribosyltransferase 4 (inactive) (Dombrock blood group) (Dombrock blood group carrier molecule splice variant III) ADP-ribosyltransferase 4 (Dombrock blood group) Dombrock glycoprotein ADP-ribosyltransferase 4 (inactive) (Dombrock blood group) (Dombrock blood group carrier molecule splice variant II) Ecto-ADP-ribosyltransferase 4 (EC 2.4.2.31) (ADP-ribosyltransferase C2 and C3 toxin-like 4) (ARTC4) (Dombrock blood group carrier molecule) (Mono(ADP-ribosyl)transferase 4) (NAD(P)(+)--arginine ADP-ribosyltransferase 4) (CD antigen CD297) NAD(P)(+)--arginine ADP-ribosyltransferase (EC 2.4.2.31) (Mono(ADP-ribosyl)transferase) |
Synonyms | DO DOK1 |
Description | |
Accessions | ENST00000430129.6 A0A3P3ZJX7 Q3KZ30 A0A3P3YWC4 A1Z625 Q3KZ29 C3W8I1 H7C2G2 ENST00000228936.6 A0A3P3YWF0 A0A3P3YW38 ENST00000544616.5 A0A166IZP3 C3W8I0 A0A0U5C078 A0A3P3YW42 A0A3P3YWJ5 ENST00000420600.1 A0A3P3YW79 A0A0U5FP74 Q93070 A0A3P3YWC5 |